Salta al contenuto
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avanzata
  • Principal factor analysis of p...
  • Citazione
  • Invia SMS
  • Invia email
  • Stampa
  • Esporta il record
    • Esporta a RefWorks
    • Esporta a EndNoteWeb
    • Esporta a EndNote
  • PLink permanente
Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.

Principal factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients.

Dettagli Bibliografici
Autori principali: Generali, D, Fox, S, Buffa, F, Berruti, A, Brizzi, M, Allevi, G, Bonardi, S, Dogliotti, L, Bottini, A, Harris, A
Natura: Conference item
Pubblicazione: 2006
  • Posseduto
  • Descrizione
  • Documenti analoghi
  • MARC21

Documenti analoghi

  • Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
    di: Generali, D, et al.
    Pubblicazione: (2006)
  • Factor analysis of predictive markers of response and resistance to primary chemo-endocrine treatment in elderly breast cancer (BC) patients
    di: Generali, D, et al.
    Pubblicazione: (2006)
  • Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
    di: Generali, D, et al.
    Pubblicazione: (2009)
  • Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
    di: Mele, T, et al.
    Pubblicazione: (2010)
  • Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients
    di: Mele, T, et al.
    Pubblicazione: (2010)

Opzioni di ricerca

  • Ultime ricerche
  • Ricerca avanzata

Cerca

  • Scorri il catalogo
  • Scorri in ordine alfabetico
  • Esplora selezioni
  • Materiali riservati (per i corsi)
  • Nuovi documenti

Serve aiuto?

  • Suggerimenti per la ricerca
  • Chiedi al bibliotecario
  • FAQ